Next Article in Journal
High-Resolution Splenic Imaging: [68Ga]Ga-Oxine Red Blood Cell PET/CT for Differentiation of Splenosis Mimicking Malignant Lymphoma
Previous Article in Journal
Diagnostic Accuracy and Reliability of Noncontrast Computed Tomography Markers for Acute Hematoma Expansion among Radiologists
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Tomography
Volume 8
Issue 6
10.3390/tomography8060243
tomography-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Parametric MRI Detects Aristolochic Acid Induced Acute Kidney Injury

by
Yingjie Mei
1,
Guixiang Yang
1,2,
Yihao Guo
3,
Kaixuan Zhao
1,
Shuyu Wu
4,
Zhongbiao Xu
5,
Shan Zhou
6,
Chenggong Yan
2,
Erdmann Seeliger
7,
Thoralf Niendorf
8,
Yikai Xu
2 and
Yanqiu Feng
1,9,10,11,*
1
School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China
2
Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
3
Department of Radiology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570311, China
4
Radiotherapy Center, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
5
Radiotherapy Center, Guangdong General Hospital, Guangzhou 510080, China
6
State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
7
Institute of Translational Physiology, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany
8
Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany
9
Guangdong Provincial Key Laboratory of Medical Image Processing & Guangdong Province Engineering Laboratory for Medical Imaging and Diagnostic Technology, Southern Medical University, Guangzhou 510515, China
10
Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence & Key Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou 510515, China
11
Department of Radiology, Shunde Hospital, Southern Medical University (The First People’s Hospital of Shunde, Foshan), Foshan 528399, China
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
Tomography 2022, 8(6), 2902-2914; https://doi.org/10.3390/tomography8060243
Submission received: 8 November 2022 / Revised: 30 November 2022 / Accepted: 5 December 2022 / Published: 10 December 2022
(This article belongs to the Section Abdominal Imaging)
Browse Figures
Review Reports Versions Notes

Abstract

:
Exposure to aristolochic acid (AA) is of increased concern due to carcinogenic and nephrotoxic effects, and incidence of aristolochic acid nephropathy (AAN) is increasing. This study characterizes renal alterations during the acute phase of AAN using parametric magnetic resonance imaging (MRI). An AAN and a control group of male Wistar rats received administration of aristolochic acid I (AAI) and polyethylene glycol (PEG), respectively, for six days. Both groups underwent MRI before and 2, 4 and 6 days after AAI or PEG administration. T2 relaxation times and apparent diffusion coefficients (ADCs) were determined for four renal layers. Serum creatinine levels (sCr) and blood urea nitrogen (BUN) were measured. Tubular injury scores (TIS) were evaluated based on histologic findings. Increased T2 values were detected since day 2 in the AAN group, but decreased ADCs and increased sCr levels and BUN were not detected until day 4. Significant linear correlations were observed between T2 of the cortex and the outer stripe of outer medulla and TIS. Our results demonstrate that parametric MRI facilitates early detection of renal injury induced by AAI in a rat model. T2 mapping may be a valuable tool for assessing kidney injury during the acute phase of AAN.

1. Introduction

The exposure to aristolochic acid (AA) has become an increasing concern due to its mutagenic, carcinogenic and nephrotoxic effects [1,2,3]. AAs are a group of compounds found in plants in the family Aristolochiaceae. These plants have long been used for various medicinal purposes, such as arthritis, abscesses, inflammation and chronic pain [2,4]. Millions of people have been affected by aristolochic acid nephropathy (AAN), which is recognized as a toxic interstitial nephropathy caused by ingestion of plants containing AA [5]. Despite measures that regulate AA consumption in many countries and regions, cases of AAN continue to occur especially in areas where traditional medicine is popular [6]. It is estimated that more than 100 million people are at risk of developing AAN worldwide [7]. AAN was demonstrated a biphasic evolution of renal injury, with the first acute phase characterized by signs of proximal tubular cell swelling and necrosis [8,9,10,11,12]. The early diagnosis of acute kidney injury (AKI) induced by AA is of great clinical importance for disease management and effective therapeutic intervention [13,14]. Despite their well-known shortcomings, serum creatinine (sCr), a surrogate marker for glomerular filtration rate (GFR), and sCre-based estimated GFR (eGFR) are still used as the standard point-of-care metrics for the diagnosis of AKI in the vast majority of medical settings, in accordance with current clinical practice guidelines [15,16]. Their diagnostic clinical utility in the case of AAN is, moreover limited, as they are surrogate markers for GFR rather than markers for injury of proximal tubules. Histologic examination remains the mainstay for diagnosis of AAN, which is invasive and susceptible to sampling error [4,13]. Therefore, a reliable non-invasive biomarker that aims for early diagnosis, disease progression monitoring and prognosis of AAN is of urgent clinical need [4].
Magnetic resonance imaging (MRI) plays an important role in kidney disease research, for not only providing excellent anatomical images but also being useful in probing renal pathophysiology using functional renal MRI techniques, such as blood oxygenation level-dependent (BOLD) image contrast, water diffusion weighted imaging (DWI), and magnetic resonance relaxometry, etc. [17,18,19,20]. Quantitative mapping of the relaxation time T2 is a well-established technique for (pre)clinical research. T2 is sensitive to both the free water content in tissue and the amount of paramagnetic deoxygenated hemoglobin (deoxyHb) per tissue volume (voxel). Therefore, T2 mapping allows the assessment of the degree of tissue edema as well as probing renal BOLD [21,22,23,24,25,26,27,28,29]. DWI, which probes the tissue microstructure through the displacement of water molecules, has been shown to provide specific information on renal tissue and is considered to be a biomarker of MR renal functional imaging [30,31,32,33].
Previous studies demonstrated that changes of renal T2 mirror characteristic pathophysiologic changes in the course of AKI development and its possible progression to chronic kidney disease (CKD). These include tissue hypoperfusion and hypoxia as observed, e.g., in the initial reperfusion phase following renal ischemia and upon administration of an x-ray contrast agent, edema formation and inflammatory infiltration, and finally, fibrosis [32,34,35]. In a study of kidney transplantation, the abrogation of the physiological gradient of T2 across the kidney reflected the loss of tubular function and identified kidney grafts with acute rejection [36]. Restricted water diffusion, which manifests itself in a reduction of the apparent diffusion coefficient (ADC), has been reported in AKI when the interstitial space was narrowed due to infiltration of inflammatory cells or fibrosis [37,38,39].
Recognizing the clinical need for diagnosis, disease management and therapy of AAN, this study examines the applicability of quantitative MRI of T2 and ADC for the assessment of early renal microstructural alterations and proximal tubular injury induced by AA.

2. Materials and Methods

2.1. Experiment Protocols

All animal experiments were performed under a protocol approved by local Animal Ethics Committee (IACUC No.: L2018132). Twenty-eight male Wistar rats with an age of 5 to 6 weeks and an initial weight ranging from 140–160 g were obtained from the Animal Center of our institute. All rats were kept in cages, housed in an animal room with stable environment (i.e., temperature, humidity and 12 h-cycle light) and provided with drinking water and rat chow ad libitum.
Figure 1 shows the schematic representation of experiment protocols performed in rats of the AAN group and the control group. Weight-matched rats were randomly assigned to AAN group (n = 22) and control group (n = 6). A previously described acute AAN model was used to induce AKI [11]. The AAN group received daily intraperitoneal injections of 40 mg/kg AAI ((Sigma-Aldrich, St. Louis, MO, USA) dissolved in polyethylene glycol (PEG) for six days. The control group received daily intraperitoneal injections of PEG the same dosage and schedule as the AAN group.
The rats were fastened 12 h before the MRI examination which was performed (at a set time of the day) for six rats from each group before, at day 2, day 4 and day 6 after AAI or PEG administration. Kidney and blood samples were collected from four rats after each MRI examination for the AAN group and after the last MRI examination for the control group.

2.2. Data Acquisition

MRI was conducted on a 7 Tesla animal scanner (Pharma Scan, Bruker Biospin, Ettlingen Germany) using a volume RF coil for transmission and 4-channel rat surface RF coil for signal reception. Rats were placed in supine position to ensure that kidneys were close to the RF coil and to reduce kidney movement caused by respiration. Anesthesia was conducted by means of inhalation of isoflurane, 5% for seduction and 2% for maintenance. Respiration was monitored and kept at a rate of 60 respiration cycles per minute using a ventilator. A circulating water blanket maintained at 38 °C was placed on the belly. High spatial resolution T2 weighted 3D Fast Spin Echo (FSE) imaging (TR/TE = 3000/66 ms; RARE factor = 20; FOV = 40 × 55 × 4 mm3; matrix = 200 × 275 × 20; voxel size = 0.2 × 0.2 × 0.2 mm3; number of averages = 1; scan duration = 13 min) was first performed for anatomical imaging. Respiratory triggering was employed to reduce respiratory motion induced artifacts. 3D T2-weighted images were acquired in coronal orientation placed parallel to both kidneys. A 2D Carr–Purcell–Meiboom–Gill (CPMG) multi-echo spin-echo sequence was performed for quantitative T2 mapping (TR/ΔTE/first TE = 1000/10/10 ms, number of echoes = 8; FOV = 40 × 55 mm2; matrix size = 133 × 183; slice thickness = 1 mm; number of slices = 8; number of averages = 2; scan duration = 6 min). For ADC mapping, single shot echo-planar DWI was applied (diffusion weighting b = 0 and 800 s/mm2, TR/TE = 3000/24 ms; FOV = 45 × 55 mm2; matrix size = 128 × 96; receiver bandwidth = 1562 Hz/pixel, slice thickness = 1 mm; number of averages = 4; acceleration factor = 2).

2.3. MR Image Analysis

T2 maps were calculated by a pixel-wise fitting using a mono-exponential fitting algorithm based on auto-regression on linear operation (ARLO) of multi-echo data [40] with Matlab 2014 software (MathWorks, Natick, MA, USA).
The principal component analysis denoising method was used for noise suppression on the original DWI images [41]. ADC maps were obtained by pixel-wise fitting of the diffusion sensitized images to Equation (1) using non-linear least squares method:
S b = S 0 · e − A D C · b
where Sb and S0 denote the MR signals with and without diffusion weighting, and b is the diffusion weighting strength. Regions of interest (ROIs) were defined for the renal cortex (CO), the outer stripe of outer medulla (OSOM), the inner stripe of outer medulla (ISOM) and inner medulla (IM). The ROIs were manually drawn on the right kidney. Mean values of T2 and ADC were estimated for each renal layer.

2.4. Biochemical Measurements and Histologic Evaluations

Blood samples were collected from the aorta and centrifuged at 3000 r/min for 10 min at 4 °C. The serum was stored at −80 °C for sCr and blood urea nitrogen concentration (BUN) measurements. sCr and BUN levels were measured using an automatic biochemical analyzer (AU480; Beckman Coulter, Pasadena, CA, USA).
Kidneys were harvested and fixed in formalin after being perfused with saline via the left ventricle while rats were under general anesthesia. Formalin fixed tissues were embedded in paraffin. Longitudinal sections were cut at a slice thickness of 2 µm and stained with hematoxylin and eosin to evaluate glomerular and tubular injury. Semi-quantitative determination of the tubular injury score (TIS) was carried out by methods reported previously [42,43]. Briefly, the tubular injury included the following categories: no injury (0), tubular epithelial cell flattening (1), brush border loss (1), cell membrane bleb formation (1–2), cytoplasmic vacuolization (1), cell necrosis (1–2), tubular lumen obstruction (1–2). Scores for all categories were accumulated for final tubular injury scoring with the maximum score being nine.

2.5. Statistical Analysis

Statistical analyses were carried out using SPSS 22.0 (IBM, New York, NY, USA). Data are presented as mean ± standard error of the mean (SEM). Longitudinal changes in T2 and ADC after AAI injection were assessed by using one-way analysis of variance (ANOVA) for repeated measurements followed by post hoc multiple comparisons. Differences in T2 and ADC between the AAN group and the control group were evaluated using unpaired t test. Correlations between TIS and MR parameters were determined by calculating the Spearman correlation coefficient. A p value lower than 0.05 was considered to be significant.

3. Results

High spatial resolution 3D T2-weighted MRI revealed structural changes of AAI-treated kidneys at different time points (Figure 2). Four renal layers can be distinguished with good tissue contrast at baseline. The contours are outlined with different colors in the zoomed image. The isotropic resolution of 0.2 mm even facilitated the visualization of the collecting ducts in the outer medulla (arrow). After the administration of AAI, the corticomedullary T2-weighted contrast differentiation (CMD) diminished at day 2 and day 4. The collecting ducts in the medulla could not be observed either at day 4. At day 6, the OSOM show marked hyperintensity compared to CO and ISOM. No distinct changes of IM were observed from T2-weighted images.
Representative T2 maps of the AAN (upper row) and the control group (lower row) are illustrated in Figure 3. For kidneys without AAI, T2 showed an increased gradient from CO to IM. For the AAN group, T2 of CO and OSOM were increased to day 6. The outcome of the statistical analysis of T2 of the AAN group is shown in Figure 4A. The T2 increase of OSOM was immediately detected at day 2 (baseline vs. day 2 p = 0.005), while that of CO was not detected until day 4 (baseline vs. day 4 p < 0.006). T2 of both layers were increased remarkably at day 6 (CO: baseline vs. day 6 p < 0.001; OSOM: baseline vs. day 6 p < 0.001). OSOM present the most pronounced T2 change: T2,day2 = 53.2 ms to T2,day6 = 69.4 ms. T2 of ISOM and IM increased until day 4 followed by a sudden decline observed at day 6, showing T2 relaxation times being smaller than at baseline.
The comparison between T2 derived from the AAN and the control group is shown in Figure 4B. For the control group, T2 remained stable from baseline to day 6 for all four renal layers. T2 of CO and OSOM was significantly higher in AAN than in the control group at day 4 and day 6 (CO: day 4 p = 0.002 and day 6 p < 0.001; OSOM: day 4 p = 0.009, day 6 p < 0.001 and p < 0.001). ISOM showed a T2 reduction (p = 0.013) only at day 6 if benchmarked against the control group. For IM, no significant T2 difference was detected between the AAN group and the control group. The T2 relaxation times of the AAN and the control group are summarized in Table 1.
The ADCs obtained for the AAN and the control group are summarized in Table 2. The results derived from the statistical analysis of the ADCs of the AAN group are shown in Figure 5A. ADC of OSOM was significantly reduced at day 6, while ADC of ISOM was significantly reduced from day 4. The time course of CO and IM showed no significant changes. The ADC comparison between the AAN and the control group is illustrated in Figure 5B. The control group showed no ADC change from baseline through day 6. The AAN group yielded ADCs lower than those of the control group, particularly in OSOM and ISOM.
The results of sCr levels and BUN are shown in Figure 6. No difference in sCr was observed between the control group and the baseline of the AAN group. For the AAN group, an increased sCr level was only detected at day 4 (control vs. day 4 p = 0.009, AAN baseline vs. day 4 p = 0.005). The increase of BUN was not detected until day 4 (control vs. day 4 p = 0.012, control vs. day 6 p = 0.008, AAN baseline vs. day 4 p = 0.012, AAN baseline vs. day 6 p = 0.008).
Renal tissue injuries of the AAN and the control group were investigated with hematoxylineosin staining (Figure 7). At baseline, examination of all kidney samples showed no significant abnormalities before treatment (Figure 7A). For the AAN group, the histologic lesions were mainly presented in proximal tubules. At day 2, the changes of the proximal tubular epithelial cells were characterized by vacuolization and swelling (Figure 7B, Δ). Inflammatory cell infiltration was detected (long arrow). At day 4, tubular necrosis (arrow head), loss of brush borders (*) and fragments of tubular epithelial cells (#) were observed (Figure 7C). The above tubular damages became diffusive at day 6 (Figure 7D). No signs of regeneration or interstitial fibrosis were observed. No histologic changes were found in the control group at day 6 (Figure 7E). The glomeruli remained intact in both groups. The AAN group revealed an averaged TISbaseline = 0, TISday2 = 3, TISday4 = 6 and TISday6 = 8. For the control group TIS = 0 was found.
The correlations between TIS and MR parameters are illustrated in Figure 8. Significant linear correlations were observed between TIS and T2 of CO (r = 0.996, p = 0.004) and OSOM (r = 0.999, p = 0.008). No correlation was observed between TIS and ADC.

4. Discussion

This study examined the feasibility of parametric MRI for the assessment of renal injury in an AAI-treated rat model using the quantitative MRI metrics T2 and ADC. T2-weighted MRI was able to separate four renal layers from each other with good tissue contrast and showed microstructural changes of different renal layers at each time point. Severe renal injury was detected with ADC mapping. T2 of OSOM and CO presents changes earlier than the standard clinical metrics (sCr and BUN) for diagnosing AKI, and was significantly correlated with TIS.
T2 mirrors free water content in tissue and the amount of deoxyHb per tissue volume. Thus, an increase of T2 may result from increased free water, e.g., due to edema formation, a decrease in deoxyHb, or a combination hereof. Lowered blood oxygenation (i.e., decreased O2 saturation of Hb) and a decrease in the blood volume fraction result in decreased deoxyHb per tissue volume. The latter can be induced by active vasoconstriction and by passive compression of intrarenal vessels. It is most probable that the observed changes in T2 represent the sum of all these effects. In the face of the relatively rigid renal capsule, edema formation and influx of immune cells will result in an ‘intrarenal compartment syndrome’: as intrarenal pressure increases, intrarenal blood vessels become compressed [29,44,45,46]. Studies on AAN revealed that the intoxication results in intrarenal vasoconstriction due to acute deficiency of vasodilatory nitric oxide (NO) [47]. Besides its effect on T2, passive compression and active vasoconstriction diminish O2 supply, thereby resulting in tissue hypoxia. Renal tissue hypoperfusion and hypoxia are a pivotal early element in the pathophysiology of AKI of various origins as well as for the promotion from AKI to CKD [48,49,50,51,52,53].
In order to improve the delineation of the rat kidney, an organ with a size about 10 × 4 × 3 mm, 3D fast spin echo T2-weighted imaging with 0.2 mm isotropic spatial resolution was employed. At day 2 and day 4, the obscurity of the distinguishable CMD can be attributed to changes in T2 that were more pronounced in the OSOM versus the CO. This could rely on a pronounced edema formation and/or pronounced decrease in deoxyHb in OSOM. It must be noted that the outer medulla (OM) is the area at risk in AKI, due to its sparse O2 delivery compared to the high O2 demands for active solute transports in the thick ascending limb of the loop of Henle and in the pars recta of the proximal tubule [48,49,53]. Therefore, the vicious cycle of hypoxia, cell damage, edema formation, and vessel compression in OM is pronounced versus the other layers. The marked hyperintensity obtained for OSOM at day 6 probably mirrors the further progression of these pathophysiologic events. In the current study, T2-weighted imaging with high spatial resolution and sufficient SNR has shown potential for the assessment of structural and blood oxygenation changes induced by AA.
The contrast changes presented on T2-weighted images of different renal layers could be further clarified and confirmed by the changes derived from T2 mapping. Among the four renal layers, T2 time course of OSOM showed the earliest change, followed by the T2 time course of CO. T2 of OSOM and CO were increased monotonically afterwards. In particular, T2 of OSOM showed the most pronounced changes. It was reported in previous studies that the proximal tubule was the main target of AA, while the glomerulus was rarely found injured at early stages of AAN [9,10,48]. Our histologic analysis revealed that injury to the proximal tubules was mainly observed for OSOM, with some spatial extension to CO. This finding suggests that the rise of T2 in OSOM and CO is in part attributable to proximal tubular epithelial cell swelling and inflammatory cells observed in histologic analysis. In addition, T2 obtained for OSOM and CO revealed significant correlations with TIS. This indicates that T2 mapping might be a useful technique for the assessment of AA-induced renal injury.
Similar to previous studies, in which T2 found for OSOM (or OM) showed the most pronounced changes after ischemia/reperfusion injury (I/R) [32,34,35], our study demonstrated the pronounced T2 changes upon AA intoxication for OSOM. While part of the underlying mechanisms differ, e.g., the primary toxic effect in AAN, our observations confirm that OM is the most vulnerable layer of the kidney in various forms of AKI. Our T2 time courses of AAI treated kidneys showed no signs of decline within the observation period. This finding is in line with clinical observations: in many patients, AAN turns out to be a rapidly progressing disease [54].
The ADCs obtained for the AAN group were significantly lower than those of the control group, especially for OSOM and ISOM. Although the ADCs of the AAN group showed a decrease over time, significant differences between the time points were barely detected. ADC reduction obtained for OSOM at day 6 and ISOM at day 4 constitute an exception. Significant ADC reduction and T2 prolongation suggest severe renal tissue damage at these time points. In previous studies, ADC reduction after AKI was reported to be associated with cell swelling and infiltration of inflammatory cells into the interstitial space [32,36,55]. Our results demonstrated ADC changes of OSOM only at day 6 after the intoxication of AAI. This indicates a decrease in the interstitial water fraction only at this stage of AAI intoxication. No correlation between ADC and TIS was observed. We hypothesize that several factors may have contributed to the insensitivity of ADC during the first 4 days. First, cell density may need to increase to a certain level to be detected by ADC changes. Second, besides apparent water diffusion, ADC also reflects blood flow in the microcirculation and tubular fluid flow in the kidney [38,39]. Hence, more sophisticated DWI models that deal with water diffusion, microcirculation and tubular flow separately such as IVIM or less constrained, data-driven non-negative least squares (NNLS) continuum approaches for renal DWI analysis should be employed in future studies [56,57,58,59].
In accordance with current clinical practice guidelines, in the vast majority of medical settings, the diagnosis of AKI is still based on the surrogate parameters for GFR, sCr and BUN. The elevation of these metrics was not detected until day 4 (sCr at day 4 and BUN at day 6) when tubular necrosis was shown. T2 changes occurred earlier and showed significant elevation at day 2 when vacuolization and swelling of proximal tubular epithelia cells were observed. This observation is consistent with previous reports concluding that the assessment of kidney injuries with blood tests is feasible when kidney function was impaired severely [60,61,62,63]. Unlike sCr and BUN results, T2 obtained for OSOM differed significantly among all time points. The well-known shortcomings of sCr and BUN for the detection of AKI of all etiologies include their low sensitivity, their exceptionally sluggish response related to their large volume of distribution, and the fact that they do not mirror early pivotal events in the pathophysiology of AKI [64,65]. Thus, T2 mapping is conceptually appealing for monitoring progression of AA-induced disease in its initial phase. Our study demonstrated another advantage of T2 mapping over sCr and BUN because T2 mapping enables layer-specific and even voxel-based evaluation of kidney alterations.
T2 showed a significant positive correlation with TIS, of which T2 of OSOM revealed the highest correlation coefficient. This finding deems T2 a suitable imaging marker candidate for the assessment of tubular injury during the acute phase of AAN.
A recognized limitation of our study is that the MRI examination covered only day 2 to day 6 after AAI administration. Recognizing the T2 alterations in OSOM observed at day 2 already, we advise to use an earlier time point for further validation of the efficacy of renal T2 mapping for the earliest possible detection of renal injury of AAN. Likewise, time points beyond day 6 should be studied in order to elucidate the further pathophysiologic events that lead to fibrosis and, ultimately, to CKD. It is an additional recognized limitation of our study that the sample size of the biochemical and histologic evaluations is relatively small.
In summary, parametric MRI facilitates assessment of microstructural and functional renal alterations induced by AA. MRI-derived parameters, in particular T2, enables detection of AAN earlier than the blood-based metrics used in today’s standard AKI diagnostics. Our results, furthermore demonstrate that high spatial resolution morphological T2-weighted MRI supports visualization of early structural changes. T2 mapping is more sensitive than DWI for the monitoring of early alterations and progression of kidney injury following AAI intoxication. This finding underlines the potential of T2 mapping as a non-invasive imaging marker for the in vivo assessment of renal alterations during the early phase of AAN.

Author Contributions

Conceptualization: Y.F. and Y.X.; Methodology, Y.M. and G.Y.; Software, Y.M. and Y.G.; Validation, Y.M., K.Z. and S.Z.; Formal Analysis, Y.M., Y.G. and Z.X.; Investigation, Y.M. and E.S.; Resources, T.N.; Data Curation, Y.M. and G.Y.; Writing—Original Draft Preparation, Y.M.; Writing—Review & Editing, T.N. and E.S.; Visualization, S.W.; Supervision, Y.F.; Project Administration, Y.F. and C.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (U21A6005), Key-Area Research and Development Program of Guangdong Province (2018B030340001, 2018B030333001), and Guangdong Basic and Applied Basic Research Foundation (2020A1515110577, 2019A1515111182).

Institutional Review Board Statement

The study was conducted under the protocol approved by the Animal Ethics Committee of Southern Medical University (protocol code L2018132, 9 July 2018).

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors have no conflict of interest to declare.

References

  1. Ng, A.W.T.; Poon, S.L.; Ni Huang, M.; Lim, J.Q.; Boot, A.; Yu, W.; Suzuki, Y.; Thangaraju, S.; Ng, C.C.Y.; Tan, P.; et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout asia. Sci. Transl. Med. 2017, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Debelle, F.D.; Vanherweghem, J.L.; Nortier, J.L. Aristolochic acid nephropathy: A worldwide problem. Kidney Int. 2008, 74, 158–169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Das, S.; Thakur, S.; Korenjak, M.; Sidorenko, V.S.; Chung, F.F.-L.; Zavadil, J. Aristolochic acid-associated cancers: A public health risk in need of global action. Nat. Rev. Cancer 2022, 22, 576–591. [Google Scholar] [CrossRef] [PubMed]
  4. Gökmen, M.R.; Cosyns, J.-P.; Arlt, V.M.; Stiborová, M.; Phillips, D.; Schmeiser, H.H.; Simmonds, M.S.; Cook, H.T.; Vanherweghem, J.-L.; Nortier, J.L.; et al. The epidemiology, diagnosis, and management of aristolochic acid nephropathy. Ann. Intern. Med. 2013, 158, 469. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Jadot, I.; Declèves, A.E.; Nortier, J.; Caron, N. An integrated view of aristolochic acid nephropathy: Update of the literature. Int. J. Mol. Sci. 2017, 18, 297. [Google Scholar] [CrossRef] [Green Version]
  6. Gökmen, M.R.; Lord, G.M. Aristolochic acid nephropathy. BMJ 2012, 344, 9–10. [Google Scholar] [CrossRef] [Green Version]
  7. Grollman, A.P. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease. Environ. Mol. Mutagen. 2013, 54, 1–7. [Google Scholar] [CrossRef]
  8. Mengs, U. Acute toxicity of aristolochic acid in rodents. Arch. Toxicol. 1987, 59, 328–331. [Google Scholar] [CrossRef]
  9. Lebeau, C.; Debelle, F.D.; Arlt, V.M.; Pozdzik, A.; De Prez, E.G.; Phillips, D.H.; Deschodt-Lanckman, M.M.; Vanherweghem, J.-L.; Nortier, J.L. Early proximal tubule injury in experimental aristolochic acid nephropathy: Functional and histological studies. Nephrol. Dial. Transplant. 2005, 20, 2321–2332. [Google Scholar] [CrossRef] [Green Version]
  10. Pozdzik, A.; Salmon, I.; Debelle, F.; Decaestecker, C.; Branden, C.V.D.; Verbeelen, D.; Deschodt-Lanckman, M.; Vanherweghem, J.-L.; Nortier, J. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 2008, 73, 595–607. [Google Scholar] [CrossRef]
  11. Pu, X.-Y.; Shen, J.-Y.; Deng, Z.-P.; Zhang, Z.-A. Plasma-specific microRNA response induced by acute exposure to aristolochic acid i in rats. Arch. Toxicol. 2017, 91, 1473–1483. [Google Scholar] [CrossRef] [PubMed]
  12. Chen, J.; Luo, P.; Wang, C.; Yang, C.; Bai, Y.; He, X.; Zhang, Q.; Zhang, J.; Yang, J.; Wang, S.; et al. Integrated single-cell transcriptomics and proteomics reveal cellular-specific responses and microenvironment remodeling in aristolochic acid nephropathy. JCI Insight 2022, 7. [Google Scholar] [CrossRef] [PubMed]
  13. Molitoris, B.A.; Melnikov, V.Y.; Okusa, M.D.; Himmelfarb, J. Technology insight: Biomarker development in acute kidney injury —What can we anticipate? Nat. Clin. Pract. Nephrol. 2008, 4, 154–165. [Google Scholar] [CrossRef] [PubMed]
  14. Lukinich-Gruia, A.T.; Nortier, J.; Pavlović, N.M.; Milovanović, D.; Popović, M.; Drăghia, L.P.; Păunescu, V.; Tatu, C.A. Aristolochic acid I as an emerging biogenic contaminant involved in chronic kidney diseases: A comprehensive review on exposure pathways, environmental health issues and future challenges. Chemosphere 2022, 297, 134111. [Google Scholar] [CrossRef]
  15. John, A.K.; Norbert, L.; Peter, A.; Rashad, S.B.; Emmanuel, A.; Burdmann, S.L.; Goldstein, C.A.; Herzog, M.J.; Andreas, K.; Andrew, S.L. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2012, 2, 1–138. [Google Scholar]
  16. Deutschegesellschaftfürnephrologie: Interdisziplinäre S2k-Leitlinie: Rationelle Labordiagnostik zur Abklärung Akuter nierenschädigungen und Progredienter Nierenerkrankungen. Available online: https://register.awmf.org/assets/guidelines/115-001l_S2k_Rationelle_Labordiagnostik_Abkl%C3%A4rung_Nierensch%C3%A4digungen_Nierenerkrankungen_2021-09_01.pdf (accessed on 28 November 2022).
  17. Caroli, A.; Pruijm, M.; Burnier, M.; Selby, N.M. Functional magnetic resonance imaging of the kidneys: Where do we stand? The perspective of the European COST Action Parenchima. Nephrol. Dial. Transpl. 2018, 33, 3–5. [Google Scholar] [CrossRef]
  18. Zhang, J.L.; Morrell, G.; Rusinek, H.; Sigmund, E.E.; Chandarana, H.; Lerman, L.O.; Prasad, P.V.; Niles, D.; Artz, N.; Fain, S.; et al. New magnetic resonance imaging methods in nephrology. Kidney Int. 2014, 85, 768–778. [Google Scholar] [CrossRef] [Green Version]
  19. De Boer, A.; Harteveld, A.A.; Stemkens, B.; Blankestijn, P.J.; Bos, C.; Msc, S.L.F.; Froeling, M.; Joles, J.A.; Verhaar, M.C.; van den Berg, N.; et al. Multiparametric renal MRI: An intrasubject test–retest repeatability study. J. Magn. Reson. Imaging 2021, 53, 859–873. [Google Scholar] [CrossRef] [Green Version]
  20. Zhao, J.M.; Clingman, C.S.; Närväinen, M.J.; Kauppinen, R.A.; Van Zijl, P.C.M. Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn. Reson. Med. 2007, 58, 592–597. [Google Scholar] [CrossRef]
  21. Kundel, H.L.; Schlakman, B.; Joseph, P.M.; Fishman, J.E.; Summers, R. Water content and nmr relaxation time gradients in the rabbit kidney. Investig. Radiol. 1986, 21, 12–17. [Google Scholar] [CrossRef]
  22. Salerno, M.; Kramer, C.M. Advances in parametric mapping with CMR imaging. JACC Cardiovasc. Imaging 2013, 6, 806–822. [Google Scholar] [CrossRef] [PubMed]
  23. Shah, B.; Anderson, S.W.; Scalera, J.; Jara, H.; Soto, J.A. Quantitative MR imaging: Physical principles and sequence design in abdominal imaging. Radiographics 2011, 31, 867–880. [Google Scholar] [CrossRef] [PubMed]
  24. Tan, H.; Thacker, J.; Franklin, T.; Prasad, P.V. Sensitivity of arterial spin labeling perfusion MRI to pharmacologically induced perfusion changes in rat kidneys. J. Magn. Reson. Imaging 2015, 41, 1124–1128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Bulluck, H.; Rosmini, S.; Abdel-Gadir, A.; Bhuva, A.N.; Treibel, T.A.; Fontana, M.; Gonzalez-Lopez, E.; Ramlall, M.; Hamarneh, A.; Sirker, A.; et al. Diagnostic performance of T1 and T2 mapping to detect intramyocardial hemorrhage in reperfused ST-segment elevation myocardial infarction (STEMI) patients. J. Magn. Reson. Imaging 2017, 46, 877–886. [Google Scholar] [CrossRef] [Green Version]
  26. Dekkers, I.A.; Lamb, H.J. Clinical application and technical considerations of T1 and T2(∗) mapping in cardiac, liver, and renal imaging. Br. J. Radiol. 2018, 91, 20180825. [Google Scholar] [CrossRef] [Green Version]
  27. Niendorf, T.; Pohlmann, A.; Arakelyan, K.; Flemming, B.; Cantow, K.; Hentschel, J.; Grosenick, D.; Ladwig, M.; Reimann, H.; Klix, S.; et al. How bold is blood oxygenation level-dependent (BOLD) magnetic resonance imaging of the kidney? Opportunities, challenges and future directions. Acta Physiol. 2015, 213, 19–38. [Google Scholar] [CrossRef] [Green Version]
  28. Prasad, P.V. Update on renal blood oxygenation level–dependent MRI to assess intrarenal oxygenation in chronic kidney disease. Kidney Int. 2018, 93, 778–780. [Google Scholar] [CrossRef]
  29. Cantow, K.; Gladytz, T.; Millward, J.M.; Waiczies, S.; Niendorf, T.; Seeliger, E. Monitoring kidney size to interpret MRI-based assessment of renal oxygenation in acute pathophysiological scenarios. Acta Physiol. 2022, vol., e13868. [Google Scholar] [CrossRef]
  30. Thoeny, H.C.; Binser, T.; Roth, B.; Kessler, T.M.; Vermathen, P. Noninvasive assessment of acute ureteral obstruction with diffusion-weighted MR imaging: A prospective study. Radiology 2009, 252, 721–728. [Google Scholar] [CrossRef] [Green Version]
  31. Inoue, T.; Kozawa, E.; Okada, H.; Inukai, K.; Watanabe, S.; Kikuta, T.; Watanabe, Y.; Takenaka, T.; Katayama, S.; Tanaka, J.; et al. Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J. Am. Soc. Nephrol. 2011, 22, 1429–1434. [Google Scholar] [CrossRef] [Green Version]
  32. Hueper, K.; Rong, S.; Gutberlet, M.; Hartung, D.; Mengel, M.; Lu, X.; Haller, H.; Wacker, F.; Meier, M.; Gueler, F. T2 relaxation time and apparent diffusion coefficient for noninvasive assessment of renal pathology after acute kidney injury in mice: Comparison with histopathology. Investig. Radiol. 2013, 48, 834–842. [Google Scholar] [CrossRef] [PubMed]
  33. Woo, S.; Cho, J.Y.; Kim, S.Y.; Kim, S.H. Intravoxel incoherent motion MRI-derived parameters and T2* relaxation time for noninvasive assessment of renal fibrosis: An experimental study in a rabbit model of unilateral ureter obstruction. Magn. Reson. Imaging 2018, 51, 104–112. [Google Scholar] [CrossRef] [PubMed]
  34. Yusa, Y.; Kundel, H.L. Magnetic resonance imaging following unilateral occlusion of the renal circulation in rabbits. Radiology 1985, 154, 151–156. [Google Scholar] [CrossRef] [PubMed]
  35. Ko, S.-F.; Yip, H.-K.; Zhen, Y.-Y.; Lee, C.-C.; Lee, C.-C.; Huang, S.-J.; Huang, C.-C.; Ng, S.-H.; Lin, J.-W. Severe bilateral ischemic-reperfusion renal injury: Hyperacute and acute changes in apparent diffusion coefficient, T1, and T2 mapping with immunohistochemical correlations. Sci. Rep. 2017, 7, 1725. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Hueper, K.; Gutberlet, M.; Bräsen, J.H.; Jang, M.-S.; Thorenz, A.; Chen, R.; Hertel, B.; Barrmeyer, A.; Schmidbauer, M.; Meier, M.; et al. Multiparametric functional MRI: Non- invasive imaging of inflammation and edema formation after kidney transplantation in mice. PLoS ONE 2016, 11, e0162705. [Google Scholar] [CrossRef] [Green Version]
  37. Caroli, A.; Schneider, M.; Friedli, I.; Ljimani, A.; De Seigneux, S.; Boor, P.; Gullapudi, L.; Kazmi, I.; A Mendichovszky, I.; Notohamiprodjo, M.; et al. Diffusion-weighted magnetic resonance imaging to assess diffuse renal pathology: A systematic review and statement paper. Nephrol. Dial. Transplant 2018, 33, ii29–ii40. [Google Scholar] [CrossRef] [Green Version]
  38. Zhou, J.-Y.; Wang, Y.-C.; Zeng, C.-H.; Ju, S.-H. Renal functional MRI and its application. J. Magn. Reson. Imaging 2018, 48, 863–881. [Google Scholar] [CrossRef]
  39. Caroli, A.; Remuzzi, A.; Lerman, L.O. Basic principles and new advances in kidney imaging. Kidney Int. 2021, 100, 1001–1011. [Google Scholar] [CrossRef]
  40. Pei, M.; Nguyen, T.D.; Thimmappa, N.D.; Salustri, C.; Dong, F.; Cooper, M.A.; Li, J.; Prince, M.R.; Wang, Y. Algorithm for fast monoexponential fitting based on auto-regression on linear operations (ARLO) of data. Magn. Reson. Med. 2015, 73, 843–850. [Google Scholar] [CrossRef] [Green Version]
  41. Manjón, J.V.; Coupé, P.; Buades, A. MRI noise estimation and denoising using non-local PCA. Med. Image Anal. 2015, 22, 35–47. [Google Scholar] [CrossRef]
  42. Paller, M.S.; Hoidal, J.R.; Ferris, T.F. Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Investig. 1984, 74, 1156–1164. [Google Scholar] [CrossRef] [PubMed]
  43. Guo, Y.; Ni, J.; Chen, S.; Bai, M.; Lin, J.; Ding, G.; Zhang, Y.; Sun, P.; Jia, Z.; Huang, S.; et al. MicroRNA-709 mediates acute tubular injury through effects on mitochondrial function. J. Am. Soc. Nephrol. 2018, 29, 449–461. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Cruces, P.; Lillo, P.; Salas, C.; Salomon, T.; Lillo, F.; Gonzalez, C.; Pacheco, A.; Hurtado, D.E. Renal decapsulation prevents intrinsic renal compartment syndrome in ischemia-reperfusion–induced acute kidney injury. Crit. Care Med. 2018, 46, 216–222. [Google Scholar] [CrossRef] [PubMed]
  45. Evans, R.G. Renal decapsulation to treat ischemic acute kidney injury. Crit. Care Med. 2018, 46, 332–333. [Google Scholar] [CrossRef] [PubMed]
  46. Herrler, T.; Tischer, A.; Meyer, A.; Feiler, S.; Guba, M.; Nowak, S.; Rentsch, M.; Bartenstein, P.; Hacker, M.; Jauch, K.-W. The intrinsic renal compartment syndrome: New perspectives in kidney transplantation. Transplantation 2010, 89, 40–46. [Google Scholar] [CrossRef] [PubMed]
  47. Declèves, A.; Jadot, I.; Colombaro, V.; Martin, B.; Voisin, V.; Nortier, J.; Caron, N. Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: An old friend with new assets. Exp. Physiol. 2016, 101, 193–206. [Google Scholar] [CrossRef] [PubMed]
  48. Brezis, M.; Rosen, S. Hypoxia of the renal medulla—Its implications for disease epstein fh, editor. N. Engl. J. Med. 1995, 332, 647–655. [Google Scholar] [CrossRef] [PubMed]
  49. Evans, R.G.; Ince, C.; Joles, J.A.; Smith, D.W.; May, C.N.; O’Connor, P.M.; Gardiner, B. Haemodynamic influences on kidney oxygenation: Clinical implications of integrative physiology. Clin. Exp. Pharmacol. Physiol. 2013, 40, 106–122. [Google Scholar] [CrossRef]
  50. Seeliger, E.; Sendeski, M.; Rihal, C.S.; Persson, P.B. Contrast-induced kidney injury: Mechanisms, risk factors, and prevention. Eur. Heart J. 2012, 33, 2007–2015. [Google Scholar] [CrossRef]
  51. Hultström, M.; Becirovic-Agic, M.; Jönsson, S. Comparison of acute kidney injury of different etiology reveals in-common mechanisms of tissue damage. Physiol. Genomics 2018, 50, 127–141. [Google Scholar] [CrossRef] [PubMed]
  52. Ma, S.; Evans, R.; Iguchi, N.; Tare, M.; Parkington, H.C.; Bellomo, R.; May, C.N.; Lankadeva, Y.R. Sepsis-induced acute kidney injury: A disease of the microcirculation. Microcirculation 2019, 26, e12483. [Google Scholar] [CrossRef] [PubMed]
  53. Scholz, H.; Boivin, F.J.; Schmidt-Ott, K.M.; Bachmann, S.; Eckardt, K.-U.; Scholl, U.I.; Persson, P.B. Kidney physiology and susceptibility to acute kidney injury: Implications for renoprotection. Nat. Rev. Nephrol. 2021, 17, 335–349. [Google Scholar] [CrossRef] [PubMed]
  54. Han, J.; Xian, Z.; Zhang, Y.; Liu, J.; Liang, A. Systematic overview of aristolochic acids: Nephrotoxicity, carcinogenicity, and underlying mechanisms. Front. Pharmacol. 2019, 10, 648. [Google Scholar] [CrossRef] [Green Version]
  55. Greite, R.; Derlin, K.; Hartung, D.; Chen, R.; Meier, M.; Gutberlet, M.; Hensen, B.; Wacker, F.; Gueler, F.; Hellms, S. Diffusion weighted imaging and t2 mapping detect inflammatory response in the renal tissue during ischemia induced acute kidney injury in different mouse strains and predict renal outcome. Biomedicines 2021, 9, 1071. [Google Scholar] [CrossRef] [PubMed]
  56. Hashim, E.; Yuen, D.A.; Kirpalani, A. Reduced flow in delayed graft function as assessed by IVIM is associated with time to recovery following kidney transplantation. J. Magn. Reson. Imaging 2021, 53, 108–117. [Google Scholar] [CrossRef]
  57. Van Baalen, S.; Leemans, A.; Dik, P.; Lilien, M.R.; ten Haken, B.; Froeling, M. Intravoxel incoherent motion modeling in the kidneys: Comparison of mono-, bi-, and triexponential fit. J. Magn. Reson. Imaging 2017, 46, 228–239. [Google Scholar] [CrossRef] [Green Version]
  58. Van der Bel, R.; Gurney-Champion, O.J.; Froeling, M.; Stroes, E.S.G.; Nederveen, A.J.; Krediet, C.T.P. A tri-exponential model for intravoxel incoherent motion analysis of the human kidney: In silico and during pharmacological renal perfusion modulation. Eur. J. Radiol. 2017, 91, 168–174. [Google Scholar] [CrossRef]
  59. Periquito, J.S.; Gladytz, T.; Millward, J.M.; Delgado, P.R.; Cantow, K.; Grosenick, D.; Hummel, L.; Anger, A.; Zhao, K.; Seeliger, E.; et al. Continuous diffusion spectrum computation for diffusion-weighted magnetic resonance imaging of the kidney tubule system. Quant. Imaging Med. Surg. 2021, 11, 3098–3119. [Google Scholar] [CrossRef]
  60. Okada, H.; Watanabe, Y.; Inoue, T.; Kobayashi, T.; Kanno, Y.; Shiota, G.; Nakamura, T.; Sugaya, T.; Fukamizu, A.; Suzuki, H. Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity. Nephrol. Dial. Transpl. 2003, 18, 2515–2523. [Google Scholar] [CrossRef] [Green Version]
  61. Kirtane, A.J.; Leder, D.M.; Waikar, S.S.; Chertow, G.M.; Ray, K.K.; Pinto, D.S.; Karmpaliotis, D.; Burger, A.J.; Murphy, S.A.; Cannon, C.P.; et al. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J. Am. Coll. Cardiol. 2005, 45, 1781–1786. [Google Scholar] [CrossRef] [Green Version]
  62. Rached, E.; Hoffmann, D.; Blumbach, K.; Weber, K.; Dekant, W.; Mally, A. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro. Toxicol. Sci. 2008, 103, 371–381. [Google Scholar] [CrossRef] [PubMed]
  63. Kim, S.Y.; Moon, A. Drug-induced nephrotoxicity and its biomarkers. Biomol. Ther. 2012, 20, 268–272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Fähling, M.; Seeliger, E.; Patzak, A.; Persson, P.B. Understanding and preventing contrast-induced acute kidney injury. Nat. Rev. Nephrol. 2017, 13, 169–180. [Google Scholar] [CrossRef] [PubMed]
  65. Porrini, E.; Ruggenenti, P.; Luis-Lima, S.; Carrara, F.; Jiménez, A.; de Vries, A.; Torres, A.; Gaspari, F.; Remuzzi, G. Estimated GFR: Time for a critical appraisal. Nat. Rev. Nephrol. 2019, 15, 177–190. [Google Scholar] [CrossRef] [PubMed]
Tomography 08 00243 g001 550
Figure 1. Schematic representation of the experimental protocol performed in rats involving an AAN group and a control group. Kidneys and blood samples were collected after each MRI examination of the AAN group, and after the last MRI examination in the control group. AAN: aristolochic acid nephropathy; AAI: aristolochic acid I; i.p.: intraperitoneal injection; PEG: polyethylene glycol.
Figure 1. Schematic representation of the experimental protocol performed in rats involving an AAN group and a control group. Kidneys and blood samples were collected after each MRI examination of the AAN group, and after the last MRI examination in the control group. AAN: aristolochic acid nephropathy; AAI: aristolochic acid I; i.p.: intraperitoneal injection; PEG: polyethylene glycol.
Tomography 08 00243 g001
Tomography 08 00243 g002 550
Figure 2. Examples of isotropic T2-weighted images of AAI-treated kidneys. At baseline, four kidney layers are outlined with contours of different colors in the zoomed image. CO, cortex; OSOM, outer stripe of outer medulla; ISOM, inner stripe of outer medulla; IM, inner medulla.
Figure 2. Examples of isotropic T2-weighted images of AAI-treated kidneys. At baseline, four kidney layers are outlined with contours of different colors in the zoomed image. CO, cortex; OSOM, outer stripe of outer medulla; ISOM, inner stripe of outer medulla; IM, inner medulla.
Tomography 08 00243 g002
Tomography 08 00243 g003 550
Figure 3. Representative renal T2 maps observed for the AAN group (upper row) and for the control group (bottom row).
Figure 3. Representative renal T2 maps observed for the AAN group (upper row) and for the control group (bottom row).
Tomography 08 00243 g003
Tomography 08 00243 g004 550
Figure 4. Statistical analysis of T2 relaxation times for the AAN group (A) and the control group (B). *** p < 0.001, ** p < 0.01, * p < 0.05. CO, cortex; OSOM, outer stripe of outer medulla; ISOM, inner stripe of outer medulla; IM, inner medulla.
Figure 4. Statistical analysis of T2 relaxation times for the AAN group (A) and the control group (B). *** p < 0.001, ** p < 0.01, * p < 0.05. CO, cortex; OSOM, outer stripe of outer medulla; ISOM, inner stripe of outer medulla; IM, inner medulla.
Tomography 08 00243 g004
Tomography 08 00243 g005 550
Figure 5. Statistical analysis of apparent water diffusion coefficients (ADCs) for the AAN group (A) and the control group (B). ** p < 0.01, * p < 0.05. CO, cortex; OSOM, outer stripe of outer medulla; ISOM, inner stripe of outer medulla; IM, inner medulla.
Figure 5. Statistical analysis of apparent water diffusion coefficients (ADCs) for the AAN group (A) and the control group (B). ** p < 0.01, * p < 0.05. CO, cortex; OSOM, outer stripe of outer medulla; ISOM, inner stripe of outer medulla; IM, inner medulla.
Tomography 08 00243 g005
Tomography 08 00243 g006 550
Figure 6. Serum creatinine levels (sCr) (left) and blood urea nigrogen (BUN) (right) of the control group and the AAI group. ** p < 0.01, * p < 0.05.
Figure 6. Serum creatinine levels (sCr) (left) and blood urea nigrogen (BUN) (right) of the control group and the AAI group. ** p < 0.01, * p < 0.05.
Tomography 08 00243 g006
Tomography 08 00243 g007 550
Figure 7. Photomicrographs (magnification, ×400) of hematoxylin–eosin staining reveal renal tissue injuries for the AAN group at baseline (A), day 2 (B), day 4 (C) and day 6 (D). At day 2, renal alterations were characterized by vacuolization and swelling of the proximal tubular epithelial cells (Δ). At day 4, tubular necrosis (arrow head), loss of brush borders (*) and fragments of tubular epithelial cells (#) were observed. The above tubular damages became massive and more serious at day 6. No signs of regeneration were observed. Inflammatory cell infiltration was detected (long arrow). No histological changes were found in the control group (E).
Figure 7. Photomicrographs (magnification, ×400) of hematoxylin–eosin staining reveal renal tissue injuries for the AAN group at baseline (A), day 2 (B), day 4 (C) and day 6 (D). At day 2, renal alterations were characterized by vacuolization and swelling of the proximal tubular epithelial cells (Δ). At day 4, tubular necrosis (arrow head), loss of brush borders (*) and fragments of tubular epithelial cells (#) were observed. The above tubular damages became massive and more serious at day 6. No signs of regeneration were observed. Inflammatory cell infiltration was detected (long arrow). No histological changes were found in the control group (E).
Tomography 08 00243 g007
Tomography 08 00243 g008 550
Figure 8. Correlations between tubular injury scores (TISbaseline = 0, TISday2 = 3, TISday4 = 6 and TISday6 = 8) and MRI parameters. CO, cortex; OSOM, outer stripe of outer medulla.
Figure 8. Correlations between tubular injury scores (TISbaseline = 0, TISday2 = 3, TISday4 = 6 and TISday6 = 8) and MRI parameters. CO, cortex; OSOM, outer stripe of outer medulla.
Tomography 08 00243 g008
Table
Table 1. Summary of T2 relaxation times obtained for the AAN group and for the control group.
Table 1. Summary of T2 relaxation times obtained for the AAN group and for the control group.
T2 (ms) GroupBaselineDay 2Day 4Day 6
COAAN50.69 ± 2.7953.98 ± 1.5959.11 ± 0.68 **61.96 ± 1.25 ***
control52.57 ± 1.5152.07 ± 1.3352.39 ± 1.3951.85 ± 1.59
OSOMAAN53.19 ± 1.2658.74 ± 1.71 *63.44 ± 0.49 ***69.43 ± 2.37 ***
control52.16 ± 0.8552.15 ± 1.0752.42 ± 1.1351.88 ± 0.98
ISOMAAN64.87 ± 0.9765.66 ± 1.6367.99 ± 2.0447.55 ± 4.84 *
control66.14 ± 1.3164.10 ± 0.4663.99 ± 0.7965.53 ± 0.90
IMAAN128.41 ± 3.01141.91 ± 6.44134.73 ± 12.21103.79 ± 17.89
control128.85 ± 2.96130.65 ± 2.52130.52 ± 2.40129.89 ± 3.47
*** p < 0.001, ** p < 0.01, * p < 0.05, compared with control rats. CO, cortex; OSOM, outer stripe of outer medulla; ISOM, inner stripe of outer medulla; IM, inner medulla.
Table
Table 2. Summary of apparent water diffusion coefficients (ADC) obtained for the AAN group and for the control group.
Table 2. Summary of apparent water diffusion coefficients (ADC) obtained for the AAN group and for the control group.
ADC (10−3 mm2/s) GroupBaselineDay 2Day 4Day 6
COAAN1.307 ± 0.091.319 ± 0.018 *1.311 ± 0.1271.006 ± 0.139 *
control1.489 ± 0.0991.566 ± 0.0861.541 ± 0.0561.585 ± 0.108
OSOMAAN1.215 ± 0.0831.256 ± 0.035 *1.295 ± 0.061 *0.975 ± 0.109 **
control1.374 ± 0.0981.532 ± 0.0981.557 ± 0.0691.508 ± 0.121
ISOMAAN1.083 ± 0.0791.142 ± 0.045 *1.027 ± 0.048 *0.809 ± 0.08 *
control1.289 ± 0.1061.417 ± 0.0921.426 ± 0.0621.451 ± 0.124
IMAAN1.393 ± 0.0911.416 ± 0.031.372 ± 0.1241.161 ± 0.146 *
control1.55 ± 0.0941.654 ± 0.0951.64 ± 0.0551.688 ± 0.141
** p < 0.01, * p < 0.05, compared with control rats. CO, cortex; OSOM, outer stripe of outer medulla; ISOM, inner stripe of outer medulla; IM, inner medulla.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mei, Y.; Yang, G.; Guo, Y.; Zhao, K.; Wu, S.; Xu, Z.; Zhou, S.; Yan, C.; Seeliger, E.; Niendorf, T.; et al. Parametric MRI Detects Aristolochic Acid Induced Acute Kidney Injury. Tomography 2022, 8, 2902-2914. https://doi.org/10.3390/tomography8060243

AMA Style

Mei Y, Yang G, Guo Y, Zhao K, Wu S, Xu Z, Zhou S, Yan C, Seeliger E, Niendorf T, et al. Parametric MRI Detects Aristolochic Acid Induced Acute Kidney Injury. Tomography. 2022; 8(6):2902-2914. https://doi.org/10.3390/tomography8060243

Chicago/Turabian Style

Mei, Yingjie, Guixiang Yang, Yihao Guo, Kaixuan Zhao, Shuyu Wu, Zhongbiao Xu, Shan Zhou, Chenggong Yan, Erdmann Seeliger, Thoralf Niendorf, and et al. 2022. "Parametric MRI Detects Aristolochic Acid Induced Acute Kidney Injury" Tomography 8, no. 6: 2902-2914. https://doi.org/10.3390/tomography8060243

APA Style

Mei, Y., Yang, G., Guo, Y., Zhao, K., Wu, S., Xu, Z., Zhou, S., Yan, C., Seeliger, E., Niendorf, T., Xu, Y., & Feng, Y. (2022). Parametric MRI Detects Aristolochic Acid Induced Acute Kidney Injury. Tomography, 8(6), 2902-2914. https://doi.org/10.3390/tomography8060243

Article Metrics

Back to TopTop